Incidence, therapy, and outcome in the management of chronic subdural hematoma in Switzerland: a population-based multicenter cohort study.

Publication

Incidence, therapy, and outcome in the management of chronic subdural hematoma in Switzerland: a population-based multicenter cohort study.

Journal Paper/Review - Sep 14, 2023

El Rahal Amir, Beck Jürgen, Ahlborn Peter, Bernasconi Corrado A, Marbacher Serge, Wanderer Stefan, Burkhardt Jan-Karl, Daniel Roy Thomas, Ferrari Andrea, Hausmann Oliver N, Kamenova Maria, Kothbauer Karl, Lutz Katharina, Mariani Luigi, Alfieri Alex, Schöni Daniel, Schucht Philippe, Raabe Andreas, Regli Luca, Kuhlen Dominique, Seule Martin Alexander, Soleman Jehuda, Starnoni Daniele, Zaldivar Julien, Zweifel Christian, Schaller Karl L, Fung Christian

Citation

El Rahal A, Beck J, Ahlborn P, Bernasconi C, Marbacher S, Wanderer S, Burkhardt J, Daniel R, Ferrari A, Hausmann O, Kamenova M, Kothbauer K, Lutz K, Mariani L, Alfieri A, Schöni D, Schucht P, Raabe A, Regli L, Kuhlen D, Seule M, Soleman J, Starnoni D, Zaldivar J, Zweifel C, Schaller K, Fung C. Incidence, therapy, and outcome in the management of chronic subdural hematoma in Switzerland: a population-based multicenter cohort study. Front Neurol 2023; 14:1206996.

Type

Journal Paper/Review (English)

Journal

Front Neurol 2023; 14

Publication Date

Sep 14, 2023

Issn Print

1664-2295

Pages

1206996

Brief description/objective

Chronic subdural hematoma (cSDH) is a disease affecting mainly elderly individuals. The reported incidence ranges from 2.0/100,000 to 58 per 100,000 person-years when only considering patients who are over 70 years old, with an overall incidence of 8.2-14.0 per 100,000 persons. Due to an estimated doubling of the population above 65 years old between 2000 and 2030, cSDH will become an even more significant concern. To gain an overview of cSDH hospital admission rates, treatment, and outcome, we performed this multicenter national cohort study of patients requiring surgical treatment of cSDH.